Sleep Aids Market

SKU: DMMD1098 | Last Updated On: Sep 22 2022 | Available Formats

> Sleep Aids Market Expected to reach a high CAGR of 4.8% By 2029

Sleep Aids Market is segmented By Product (Sleep apnea devices (Positive airway pressure (PAP) devices, Facial interfaces devices, Oral devices, Adaptive servo-ventilation(ASV), Others), By Medication (Prescription drugs, Over-the-counter (OTC) drugs, Herbal remedies), Mattresses, and pillows, Others), By Disorder Type (Insomnia, Sleep Deprivation, Narcolepsy, Sleep Apnea), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

[150 Pages Report] Sleep Aids Market is expected to grow at a CAGR of 4.8% during the forecasting period (2022-2029).

Sleep Aids Market - Strategic Insights



Market CAGR


Segments Covered

By Product, By Medication, By Disorder Type, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To Get a Free Sample Click here

Sleep aids are pills medical devices used to treat and diagnose various sleep disturbances and disorders, such as sleep apnea and insomnia. Products such as specialized mattresses and pillows which can induce sleep are also categorized as sleeping aids. Sleep aid medications are commonly referred to as hypnotics or sleeping pills. Hypnotics are a class of psychoactive drugs whose primary function is to induce sleep and to treat insomnia (sleeplessness). These sleep disorders are expected to adversely affect human health and lead to several chronic diseases, such as high blood pressure, diabetes. Thus, it is essential to treat and diagnose these disorders at an early stage. Growing

Market Dynamics

Increasing prevalence of insomnia and obstructive sleep apnea (OSA) disorders, rising use of portable sleep apnea devices, improving healthcare facilities, the surge in demand for sleeping pills attributed to stressful modern lifestyle, and increasing geriatric population are the key factors driving the growth of the market. According to Centres for Disease Control and Prevention (CDC), in 2017, around 49.2 million people across the globe have sleeping issues. Increasing awareness about sleep disorders and technological advancements are boosting the global sleep aids market.

Growing awareness initiatives by various organizations to educate people and medical practitioners about healthy sleep habits are propelling the global sleep aids market. For instance, in March 2018, the National Sleep Foundation conducted the sleep awareness week with the theme ‘Begin with Sleep Moreover’.

However, the adverse effects of using sleeping aids are hampering the global sleep aids market. In older adults, using these pills can cause memory problems and drug addiction issues.

Segment Analysis

Based on product the global Sleep Aids market is broadly segmented as mattress and pillows, medication, sleep apnea devices, and others. Among all these mattresses and pillows accounted for a major market share in 2018, and it is projected to grow at a significant pace over the forecast period (2019-2026). This is attributed to the fact that mattresses and pillows are a cost-effective solution, due to which these are widely adopted among the global population. Additionally, technical advancements and developments by manufacturers are driving the mattresses and pillows segment. In May 2017, DeVilbiss Healthcare introduced the P903 Full Electric Expandable Width Low Height Long-Term Care (LTC) bed, to its premium line of mattresses and bedding products.

Sleeping aid drugs include prescription drugs such as benzodiazepine, antidepressants, orexin antagonists, and over-the-counter (OTC) drugs such as antihistamines, melatonin, and others. Among these, uptake of OTC drugs is growing at a significant rate, owing to low cost and no adverse effects compared to others. Sleep aid devices include positive airway pressure (PAP) machines and oral appliances. Oral appliance therapy is an effective, non-invasive treatment. It is more comfortable, easy to wear, and portable.

Based on the sleep disorder Sleep Deprivation, Narcolepsy, insomnia, sleep apnea, and others. Among all these insomnia accounted for a major market share in 2018. It is due to the rise in the prevalence of the number of insomnia cases over the years. Over the forecast period (2019-2026) sleep apnea disorder is growing at a high pace. The growing prevalence of OSA (Obstructive Sleep Apnea), along with technological advancements are anticipated to boost the sleep apnea segment. According to WHO (World Health Organization), in 2018, the prevalence of sleep apnea impacts more than 936 million people worldwide which is nearly ten times greater than the 2007 estimation. Thus, the growing incidence of OSA is expected to drive the global sleep aids market.

Geographical Analysis

The global Sleep Aids market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America accounted for a major share in the global sleeping aids market in 2018. This is attributed to the rising number of sleep apnea disorders. The Asia Pacific is expected to be the fastest-growing region in the global sleeping aids market, owing to the increasing demand for sleeping pills due to stressful modern lifestyles. With the ever-increasing geriatric population, the frequency of sleep disorders is rising, which further creates demand for these products. According to the Food and Drug Administration (FDA), in 2014, Japan sold around 339 million sleeping pills.

Competitive Analysis

Significant players of the global sleep aids market are Teva Pharmaceutical Industries Ltd., Merck & Co., Sanofi, DeVilbiss Healthcare LLC. (Drive Medical), Pfizer Inc., SleepMed Inc., Cadwell Laboratories Inc., Compumedics Limited, Natus Medical Incorporated, GlaxoSmithKline plc., and others. The product launches, collaboration, and product agreements, and other key developments are the dominating strategies adopted by the market players to enhance their product portfolio in the global sleep aids market.

·     In April 2019, UCHealth incorporated a new sleep apnea advanced device, remedy implantable device, to treat central sleep apnea.

·     In March 2019, the FDA approved Jazz Pharmaceuticals’ Sunosi (solriamfetol) drug to treat obstructive sleep apnea (OSA).

·     In January 2015, DeVilbiss Healthcare added the new Quest™ Full Face CPAP Mask to its growing line of CPAP therapy interfaces.


What is the Sleep Aids Market growth?

The market is growing at a CAGR of 4.8%

What is Sleep Aids Market size in 2021

The Sleep Aids Market size was valued at USD YY million in 2021

Who are the key players in Sleep Aids Market?

Teva Pharmaceutical Industries Ltd., Merck & Co., Sanofi, DeVilbiss Healthcare LLC. (Drive Medical), Pfizer Inc.

Trending Topics

Sleep Apnea Devices Market 

Smoking Cessation Aids Market

Bone Anchored Hearing Aids Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!